Maltol
CAS 118-71-8
Maltol (CAS 118-71-8) is a Phase 3 pharmaceutical compound with 4 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Clinical Development Phase
Highest clinical development phase rendered from the matched compound identifier rows.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | GI50 | 94783.33854545455 nM | 55 | - |
| - | Potency | 19191.81 nM | 9 | - |
| - | IC50 | 109869.71250000001 nM | 2 | - |
| - | IC50 | 6.3100000000000005 ug.mL-1 | 2 | - |
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| MALTOL | 1362894 | SU | MTHSPL |
| maltol | 1362894 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Maltol used for in pharmaceutical contexts?
Maltol (CAS 118-71-8) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Maltol?
No adverse-event association or SIDER side-effect rows are rendered for Maltol in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Maltol also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Maltol with EU status "prohibited".
What clinical phase is Maltol in?
Maltol is rendered with ChEMBL max phase 3.